MORPHINE SULFATE; NALTREXONE HYDROCHLORIDE | ALPHARMA PHARMS | ||
20MG;0.8MG,30MG;1.2MG,50MG;2MG,60MG;2.4MG,80MG;3.2MG,100MG;4MG | |||
Yes | Yes | ||
2029-Nov-07 | Expired | ||
None | None | ||
None | No | ||
EMBEDA is a combination opioid agonist/opioid antagonist product indicated for the management of pain severe enough to require daily, around-the-clock, long-term opioid treatment and for which alternative treatment options are inadequate. |
0 | 0 | 0 |
Total Other Developers | None |
---|
Drugs with Suitability | No |
---|
20MG;0.8MG | ** | ** | - | - | - |
30MG;1.2MG | ** | ** | - | - | - |
50MG;2MG | ** | ** | - | - | - |
60MG;2.4MG | ** | ** | - | - | - |
80MG;3.2MG | ** | ** | - | - | - |
100MG;4MG | ** | ** | - | - | - |
NDA Sales Available | Total Generic Sales Available |
---|---|
No | 0 |
ANDA No | Generic Co | Manufacturer Name | Operations | Manufacturer Address | Country |
---|
Download GenUS Drug Report
Research Delta Advisor, G4,Sani Apartment, Bank of india lane, Ellora park, Vadodara 390023
+91 94997 68112
nimish@researchdelta.com